{{Rsnum
|rsid=2364722
|Gene=NFE2L2
|Chromosome=2
|position=177260059
|Orientation=plus
|GMAF=0.3526
|Gene_s=NFE2L2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 43.8 | 43.8 | 12.5
| HCB | 29.6 | 47.4 | 23.0
| JPT | 15.2 | 42.9 | 42.0
| YRI | 66.4 | 31.5 | 2.1
| ASW | 66.1 | 33.9 | 0.0
| CHB | 29.6 | 47.4 | 23.0
| CHD | 17.8 | 58.9 | 23.4
| GIH | 18.8 | 60.4 | 20.8
| LWK | 75.2 | 24.8 | 0.0
| MEX | 34.5 | 48.3 | 17.2
| MKK | 73.1 | 23.7 | 3.2
| TSI | 52.9 | 43.1 | 3.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=21774808
|Title=An interaction between Nrf2 polymorphisms and smoking status affects annual decline in FEV1: a longitudinal retrospective cohort study
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}